Viewing Study NCT03290794


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2025-12-31 @ 3:43 PM
Study NCT ID: NCT03290794
Status: COMPLETED
Last Update Posted: 2023-06-09
First Post: 2017-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical Practice
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module